Methotrexate for Inflammatory Bowel Diseases - New Developments
Keyword(s):
The Past
◽
Methotrexate (MTX) is an established therapy for patients with steroid-dependent Crohn's disease (CD). MTX is also frequently used in combination with anti-TNF agents to suppress anti-drug antibody formation. It has been suggested in the past that MTX lacks any clinical effectiveness in patients with ulcerative colitis (UC); however, newer data at least partially contradict this assumption. The following review will discuss recent data for the use of MTX in CD, UC and in combination with anti-TNF agents.
2015 ◽
Vol 52
(1)
◽
pp. 50-54
◽
2001 ◽
Vol 96
(2)
◽
pp. 442-448
◽
1999 ◽
Vol 14
(1)
◽
pp. 52-57
◽
2016 ◽
Vol 2016
◽
pp. 1-7
◽
Keyword(s):